Eline A Verberne1, Shuxiang Goh2, Jade England3, Mieke M van Haelst4, Philippe M Campeau5, Manon van Ginkel1,6, Louise Rafael-Croes6, Saskia Maas1, Abeltje Polstra1, Yuri A Zarate7, Katherine A Bosanko7, Kieran B Pechter8, Emma Bedoukian9, Kosuke Izumi9, Ayeshah Chaudhry10,11, Nathaniel H Robin12, Megan Boothe12, Natalie C Lippa13, Vimla Aggarwal13, Darryl C De Vivo14, Anna Lehman15, Causes Study15, Sylvia Stockler16, Ange-Line Bruel17, Bertrand Isidor18, Jennifer Lemons19, David F Rodriguez-Buritica19, Christopher M Richmond20,21, Zornitza Stark20,22, Pankaj B Agrawal23, R Frank Kooy24, Marije E C Meuwissen24,25, David A Koolen26, Rolf Pfundt26, Agne Lieden27,28, Britt-Marie Anderlid27,28, Dagmar Glatz29, Marcel M A M Mannens1, Madhura Bakshi2, Frédérick A Mallette29. 1. Department of Clin Genet, Amsterdam UMC, Amsterdam Reproduction and Development Research Institute, University of Amsterdam, Amsterdam, The Netherlands. 2. Department of Clin Genet, Liverpool Hospital, Sydney, Australia. 3. Department of Pediatrics, University of Montreal, Montreal, QC, Canada. 4. Department of Clin Genet, Amsterdam UMC, Amsterdam Reproduction and Development Research Institute, University of Amsterdam, Amsterdam, The Netherlands. m.vanhaelst@amsterdamumc.nl. 5. Department of Pediatrics, University of Montreal, Montreal, QC, Canada. p.campeau@umontreal.ca. 6. Department of Pediatrics, Dr. Horacio E. Oduber Hospital, Oranjestad, Aruba. 7. Section of Genetics and Metabolism, Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, USA. 8. Division of Genomic Diagnostics, Children's Hospital of Philadelphia, Philadelphia, PA, USA. 9. Roberts Individualized Medical Genetics Center and the Division of Hum Genet, Children's Hospital of Philadelphia, Philadelphia, PA, USA. 10. Department of Laboratory Medicine and Genetics, Trillium Health Partners, Mississauga, ON, Canada. 11. Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada. 12. Department of Genetics, University of Alabama at Birmingham (UAB), Birmingham, AL, USA. 13. Institute for Genomic Medicine, Columbia University Irving Medical Center, New York, NY, USA. 14. Departments of Neurology and Pediatrics, Columbia University Irving Medical Center, New York, NY, USA. 15. Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. 16. Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. 17. Équipe Génétique des Anomalies du Développement (GAD), CHU Dijon-Bourgogne, Dijon, France. 18. Service de génétique médicale, CHU de Nantes, Nantes, France. 19. Department of Pediatrics, UTHealth McGovern Medical School, Houston, TX, USA. 20. Victorian Clin Genet Services, Murdoch Children's Research Institute, Melbourne, VIC, Australia. 21. School of Medicine, Griffith University, Gold Coast, QLD, Australia. 22. Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia. 23. Divisions of Newborn Medicine and Genetics & Genomics, Department of Pediatrics, Manton Center for Orphan Disease Research, Boston Children's Hospital, Boston, MA, USA. 24. Department of Medical Genetics, University of Antwerp, Antwerp, Belgium. 25. Department of Medical Genetics, University Hospital Antwerp, Antwerp, Belgium. 26. Department of Hum Genet, Radboud Institute for Molecular Life Sciences and Donders Institute for Brain, Cognition and Behaviour, Radboud university medical center, Nijmegen, The Netherlands. 27. Department of Clin Genet, Karolinska University Hospital, Stockholm, Sweden. 28. Department of molecular medicine and surgery, Karolinska Institutet, Stockholm, Sweden. 29. Département de Médecine, Faculté de médecine, Université de Montréal, and Centre de Recherche de l'Hôpital Maisonneuve-Rosemont, Montreal, QC, Canada.
Abstract
PURPOSE: JARID2, located on chromosome 6p22.3, is a regulator of histone methyltransferase complexes that is expressed in human neurons. So far, 13 individuals sharing clinical features including intellectual disability (ID) were reported with de novo heterozygous deletions in 6p22-p24 encompassing the full length JARID2 gene (OMIM 601594). However, all published individuals to date have a deletion of at least one other adjoining gene, making it difficult to determine if JARID2 is the critical gene responsible for the shared features. We aim to confirm JARID2 as a human disease gene and further elucidate the associated clinical phenotype. METHODS: Chromosome microarray analysis, exome sequencing, and an online matching platform (GeneMatcher) were used to identify individuals with single-nucleotide variants or deletions involving JARID2. RESULTS: We report 16 individuals in 15 families with a deletion or single-nucleotide variant in JARID2. Several of these variants are likely to result in haploinsufficiency due to nonsense-mediated messenger RNA (mRNA) decay. All individuals have developmental delay and/or ID and share some overlapping clinical characteristics such as facial features with those who have larger deletions involving JARID2. CONCLUSION: We report that JARID2 haploinsufficiency leads to a clinically distinct neurodevelopmental syndrome, thus establishing gene-disease validity for the purpose of diagnostic reporting.
PURPOSE: JARID2, located on chromosome 6p22.3, is a regulator of histone methyltransferase complexes that is expressed in human neurons. So far, 13 individuals sharing clinical features including intellectual disability (ID) were reported with de novo heterozygous deletions in 6p22-p24 encompassing the full length JARID2 gene (OMIM 601594). However, all published individuals to date have a deletion of at least one other adjoining gene, making it difficult to determine if JARID2 is the critical gene responsible for the shared features. We aim to confirm JARID2 as a human disease gene and further elucidate the associated clinical phenotype. METHODS: Chromosome microarray analysis, exome sequencing, and an online matching platform (GeneMatcher) were used to identify individuals with single-nucleotide variants or deletions involving JARID2. RESULTS: We report 16 individuals in 15 families with a deletion or single-nucleotide variant in JARID2. Several of these variants are likely to result in haploinsufficiency due to nonsense-mediated messenger RNA (mRNA) decay. All individuals have developmental delay and/or ID and share some overlapping clinical characteristics such as facial features with those who have larger deletions involving JARID2. CONCLUSION: We report that JARID2 haploinsufficiency leads to a clinically distinct neurodevelopmental syndrome, thus establishing gene-disease validity for the purpose of diagnostic reporting.
Authors: Diego Pasini; Paul A C Cloos; Julian Walfridsson; Linda Olsson; John-Paul Bukowski; Jens V Johansen; Mads Bak; Niels Tommerup; Juri Rappsilber; Kristian Helin Journal: Nature Date: 2010-03-11 Impact factor: 49.962
Authors: Gang Li; Raphael Margueron; Manching Ku; Pierre Chambon; Bradley E Bernstein; Danny Reinberg Journal: Genes Dev Date: 2010-02-01 Impact factor: 11.361
Authors: J L Bergé-Lefranc; P Jay; A Massacrier; P Cau; M G Mattei; S Bauer; C Marsollier; P Berta; M Fontes Journal: Hum Mol Genet Date: 1996-10 Impact factor: 6.150
Authors: Matthew R Mysliwiec; Clayton D Carlson; Josh Tietjen; Holly Hung; Aseem Z Ansari; Youngsook Lee Journal: J Biol Chem Date: 2011-11-21 Impact factor: 5.157
Authors: David Landeira; Hakan Bagci; Andrzej R Malinowski; Karen E Brown; Jorge Soza-Ried; Amelie Feytout; Zoe Webster; Elodie Ndjetehe; Irene Cantone; Helena G Asenjo; Neil Brockdorff; Thomas Carroll; Matthias Merkenschlager; Amanda G Fisher Journal: Cell Rep Date: 2015-07-16 Impact factor: 9.423
Authors: Xiaohua Shen; Woojin Kim; Yuko Fujiwara; Matthew D Simon; Yingchun Liu; Matthew R Mysliwiec; Guo-Cheng Yuan; Youngsook Lee; Stuart H Orkin Journal: Cell Date: 2009-12-24 Impact factor: 41.582
Authors: Eline A Verberne; Liselot van der Laan; Sadegheh Haghshenas; Kathleen Rooney; Michael A Levy; Mariëlle Alders; Saskia M Maas; Sandra Jansen; Agne Lieden; Britt-Marie Anderlid; Louise Rafael-Croes; Philippe M Campeau; Ayeshah Chaudhry; David A Koolen; Rolph Pfundt; Anna C E Hurst; Frederic Tran-Mau-Them; Ange-Line Bruel; Laetitia Lambert; Bertrand Isidor; Marcel M A M Mannens; Bekim Sadikovic; Peter Henneman; Mieke M van Haelst Journal: Int J Mol Sci Date: 2022-07-20 Impact factor: 6.208
Authors: Eline A Verberne; Jonne M Westermann; Tamar I de Vries; Ginette M Ecury-Goossen; Shirley M Lo-A-Njoe; Meindert E Manshande; Sonja Faries; Hans D Veenhuis; Patricia Philippi; Farah A Falix; Irsa Rosina-Angelista; Maria Ponson-Wever; Louise Rafael-Croes; Patricia Thorsen; Eric Arends; Maartje de Vroomen; Sietse Q Nagelkerke; Martijn Tilanus; Lars T van der Veken; Karin Huijsdens-van Amsterdam; Anne-Marie van der Kevie-Kersemaekers; Mariëlle Alders; Marcel M A M Mannens; Mieke M van Haelst Journal: Am J Med Genet A Date: 2022-03-07 Impact factor: 2.578